Surging Incidence of Anaphylaxis Supporting Auto-Injectors Market Growth
The growing
prevalence of anaphylaxis and surging aging population are two of the key
factors responsible for the growth of the auto-injectors market. The market is predicted to advance
at a CAGR of 18.6% during the forecast period (2017–2023).
An auto-injector is a medical device used for
injecting a particular dose of drugs in patients. Most of the auto-injectors
are spring-loaded syringes, designed for the safe dispensation of drugs with
ease. Based on product, the auto-injectors market is bifurcated into prefilled
and fillable injectors.
On the basis
of therapeutic application, the auto-injectors market is categorized into
anaphylaxis, rheumatoid arthritis (RA), multiple sclerosis (MS), and others.
Out of these, during the 2013–2016 period, the anaphylaxis category dominated
the market in terms of revenue, and it is predicted to continue dominating it
during the 2017–2023 period. This is attributed to the surging incidence of
anaphylaxis and growing awareness on auto-injectors for treating several
allergies effectively. Anaphylaxis is a fatal and severe allergic condition
that can present in any age or gender.
Request
to Get the Sample Pages at:
As per the
World Allergy Organization, in 2013, nearly 250.0 million people suffered from
food allergies across the globe. The incidence of food allergy is more common
in children compared to adults. Aspirin, ibuprofen, chemotherapy drugs,
antibiotics containing sulfonamides, and other non-steroidal anti-inflammatory
drugs can trigger anaphylaxis, which may result in death. There are various
types of allergies, such as general, mold, pet, latex, pollen, and skin
allergy, which can lead to anaphylaxis. Further, the growing demand for
biological drug therapies is playing an important role in the growth of the
auto-injectors market.
Make
Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=auto-injectors-market
Thus, it can
be concluded that the increasing number of biologic drug therapies and surging
prevalence of anaphylaxis are contributing to the growth of the market.
Comments
Post a Comment